2.46
price down icon4.28%   -0.11
pre-market  Vorhandelsmarkt:  2.46  
loading
Schlusskurs vom Vortag:
$2.57
Offen:
$2.57
24-Stunden-Volumen:
8.07M
Relative Volume:
0.92
Marktkapitalisierung:
$2.33B
Einnahmen:
$1.31M
Nettoeinkommen (Verlust:
$-597.65M
KGV:
-2.5361
EPS:
-0.97
Netto-Cashflow:
$-425.62M
1W Leistung:
-5.02%
1M Leistung:
+5.13%
6M Leistung:
-18.27%
1J Leistung:
-33.87%
1-Tages-Spanne:
Value
$2.41
$2.57
1-Wochen-Bereich:
Value
$2.38
$2.65
52-Wochen-Spanne:
Value
$1.83
$7.48

Immunitybio Inc Stock (IBRX) Company Profile

Name
Firmenname
Immunitybio Inc
Name
Telefon
(844) 696-5235
Name
Adresse
3530 JOHN HOPKINS COURT, SAN DIEGO
Name
Mitarbeiter
685
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
IBRX's Discussions on Twitter

Vergleichen Sie IBRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IBRX
Immunitybio Inc
2.46 2.43B 1.31M -597.65M -425.62M -0.97
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.64 101.35B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.00 58.66B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
562.27 59.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
737.56 44.01B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
340.70 36.56B 3.81B -644.79M -669.77M -6.24

Immunitybio Inc Stock (IBRX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-20 Hochstufung Piper Sandler Neutral → Overweight
2025-03-06 Eingeleitet H.C. Wainwright Buy
2025-01-10 Eingeleitet BTIG Research Buy
2023-05-12 Herabstufung Piper Sandler Overweight → Neutral
2022-08-03 Eingeleitet Jefferies Buy

Immunitybio Inc Aktie (IBRX) Neueste Nachrichten

pulisher
Sep 30, 2025

Will ImmunityBio Inc. stock outperform tech sector in 20252025 Bull vs Bear & Verified Entry Point Detection - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Does ImmunityBio Inc. show high probability of reboundJuly 2025 PostEarnings & Community Trade Idea Sharing Platform - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Real time social sentiment graph for ImmunityBio Inc.Inflation Watch & Fast Entry Momentum Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

ImmunityBio Inc. stock retracement – recovery analysisIndex Update & Risk Controlled Swing Trade Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

What MACD and RSI say about ImmunityBio Inc.2025 Market WrapUp & Stock Timing and Entry Methods - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Short interest data insights for ImmunityBio Inc.2025 Key Highlights & Weekly Setup with ROI Potential - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

How ImmunityBio Inc. stock reacts to job market dataWeekly Trade Review & Capital Protection Trading Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

What drives ImmunityBio Inc stock priceStock Liquidity Analysis & Free Trend Following Techniques - earlytimes.in

Sep 29, 2025
pulisher
Sep 29, 2025

Why ImmunityBio Inc. (26CA) stock is a strong analyst pickTrend Reversal & High Conviction Trade Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Will ImmunityBio Inc. stock benefit from infrastructure spendingMarket Weekly Review & Accurate Technical Buy Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Evaluating ImmunityBio Inc. with trendline analysisWeekly Loss Report & Reliable Entry Point Trade Alerts - newser.com

Sep 29, 2025
pulisher
Sep 28, 2025

ImmunityBio Inc Stock Analysis and ForecastDividend Cut Warnings & Outstanding Investment Portfolio - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Is ImmunityBio Inc a good long term investmentTrading Volume Trends & Small Entry Trading Portfolio - Early Times

Sep 28, 2025
pulisher
Sep 27, 2025

User - FinancialContent

Sep 27, 2025
pulisher
Sep 26, 2025

ImmunityBio Inc. (IBRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Sep 26, 2025
pulisher
Sep 26, 2025

FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone - Investing News Network

Sep 26, 2025
pulisher
Sep 26, 2025

Plancorp LLC Takes Position in ImmunityBio, Inc. $IBRX - MarketBeat

Sep 26, 2025
pulisher
Sep 20, 2025

Retail Trends: Is ImmunityBio Inc part of any major indexJuly 2025 Weekly Recap & Intraday High Probability Alerts - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

ImmunityBio’s (IBRX) ANKTIVA Shows Survival Gains in Lung Cancer Patients - Insider Monkey

Sep 20, 2025
pulisher
Sep 19, 2025

Will CTGO outperform small cap indexesQuarterly Trade Summary & Low Risk Investment Opportunities - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Market Review: Should I add QULL stock to my portfolioPortfolio Profit Report & Daily Growth Stock Tips - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Fed Watch: Will ImmunityBio Inc outperform its industry peersMarket Movement Recap & Long-Term Capital Growth Ideas - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

An Intrinsic Calculation For ImmunityBio, Inc. (NASDAQ:IBRX) Suggests It's 50% Undervalued - 富途牛牛

Sep 19, 2025
pulisher
Sep 19, 2025

Earnings Update: Can ImmunityBio Inc. stock double in the next year2025 Market WrapUp & Accurate Entry/Exit Alerts - خودرو بانک

Sep 19, 2025
pulisher
Sep 18, 2025

Biotech Breakouts: 3 Stocks With Massive Upside Potential - Investing.com

Sep 18, 2025
pulisher
Sep 17, 2025

Biotech Breakouts: 3 Stocks With Massive Upside Potential - MarketBeat

Sep 17, 2025
pulisher
Sep 17, 2025

A Look at ImmunityBio (IBRX) Valuation Following New Data on ANKTIVA’s Impact in Advanced Lung Cancer - Sahm

Sep 17, 2025
pulisher
Sep 17, 2025

Insider Sell: Is ImmunityBio Inc stock a smart retirement pick2025 Biggest Moves & Real-Time Market Sentiment Reports - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

ImmunityBio Stock Breaks Out Of Long Slump, Tests $3 Zone: Ex-UBS Analyst Flags ‘Huge’ Bullish Signals - Stocktwits

Sep 17, 2025
pulisher
Sep 16, 2025

ETF Watch: Is ImmunityBio Inc. a speculative investmentQuarterly Trade Report & Technical Confirmation Trade Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Gainers Report: Is ImmunityBio Inc. forming a double bottomMarket Sentiment Summary & Technical Pattern Based Signals - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Market Leaders: Will ImmunityBio Inc stock benefit from M AJuly 2025 Closing Moves & Daily Oversold Stock Bounce Ideas - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Multi factor analysis applied to ImmunityBio Inc.Weekly Trade Analysis & Accurate Technical Buy Alerts - newser.com

Sep 16, 2025
pulisher
Sep 16, 2025

ImmunityBio's (IBRX) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Is ImmunityBio Inc. gaining market shareWeekly Trend Report & Free Weekly Chart Analysis and Trade Guides - khodrobank.com

Sep 16, 2025
pulisher
Sep 15, 2025

Recap Report: Is CDTG stock technically oversoldQuarterly Growth Report & Safe Entry Zone Identification - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Tech Rally: Does ImmunityBio Inc have a sustainable dividendTake Profit & Consistent Income Trade Ideas - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Aug Chart Watch: Is ImmunityBio Inc a cyclical or defensive stockJuly 2025 Weekly Recap & Risk Managed Investment Strategies - khodrobank.com

Sep 15, 2025
pulisher
Sep 15, 2025

ImmunityBio ($IBRX) Is Paying a $10.5M Settlement to Investors — Here’s How to Get Your Share - TradingView

Sep 15, 2025
pulisher
Sep 15, 2025

RSI Check: Will ImmunityBio Inc benefit from rate cutsPortfolio Risk Report & Precise Swing Trade Entry Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

H.C. Wainwright Reiterates Buy Rating on ImmunityBio, Keeps PT at $8 - Yahoo Finance

Sep 15, 2025
pulisher
Sep 15, 2025

Real time breakdown of ImmunityBio Inc. stock performanceWall Street Watch & Long-Term Capital Growth Ideas - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

ImmunityBio (NASDAQ:IBRX) Trading 7.3% HigherHere's Why - MarketBeat

Sep 15, 2025
pulisher
Sep 14, 2025

Why ImmunityBio, Inc. (IBRX) Surged On Thursday - MSN

Sep 14, 2025
pulisher
Sep 14, 2025

ImmunityBio's (IBRX) Buy Rating Reiterated at D. Boral Capital - MarketBeat

Sep 14, 2025
pulisher
Sep 12, 2025

Why ImmunityBio Inc. stock remains a top recommendationJuly 2025 Gainers & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn

Sep 12, 2025
pulisher
Sep 11, 2025

ImmunityBio: Still Too Early To Judge Anktiva, Although Clock Is Ticking (NASDAQ:IBRX) - Seeking Alpha

Sep 11, 2025
pulisher
Sep 10, 2025

Breakthrough Findings from Phase 2 QUILT-3.055 Study in NSCLCImmunityBio, Inc. - Oncodaily

Sep 10, 2025
pulisher
Sep 10, 2025

H.C. Wainwright reiterates Buy rating on ImmunityBio stock, citing promising lung cancer data - Investing.com India

Sep 10, 2025

Finanzdaten der Immunitybio Inc-Aktie (IBRX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
Kapitalisierung:     |  Volumen (24h):